Screener
Agios Pharmaceuticals AGIO Operating margin
Operating margin at other companies
Other financials
Where this comes from
Calculated from Agios Pharmaceuticals’s reported figures.
Based on trailing twelve months.
The source filing: Agios Pharmaceuticals’s 10-Q, filed July 30, 2026. Open the filing →
- Filed
- Jul 30, 2026, 9:56 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001439222-26-000118
FAQ
- What is Agios Pharmaceuticals's operating margin?
- Agios Pharmaceuticals (AGIO) reported operating margin of -466.8% in Q2 2026.
- How has Agios Pharmaceuticals's operating margin changed year-over-year?
- Agios Pharmaceuticals's operating margin increased by 58.7% year-over-year, from -1,129.1% to -466.8%.
- What is the long-term trend for Agios Pharmaceuticals's operating margin?
- Over 4 years (2020 to 2025), Agios Pharmaceuticals's operating margin has grown at a 53.9% compound annual growth rate (CAGR), from -155.6% to -873.9%.
- What does operating margin mean?
- Operating income as a percentage of revenue (trailing twelve months). Captures profitability from core operations after both cost of revenue and operating expenses, but before interest and taxes.
Ask your AI about Agios Pharmaceuticals's operating margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude